These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35626292)

  • 1. Anosognosia in Dementia: Evaluation of Perfusion Correlates Using 99mTc-HMPAO SPECT and Automated Brodmann Areas Analysis.
    Valotassiou V; Sifakis N; Tzavara C; Lykou E; Tsinia N; Kamtsadeli V; Sali D; Angelidis G; Psimadas D; Theodorou E; Tsougos I; Papageorgiou SG; Georgoulias P; Papatriantafyllou J
    Diagnostics (Basel); 2022 May; 12(5):. PubMed ID: 35626292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences of apathy perfusion correlates between Alzheimer's disease and frontotemporal dementia. A 99mTc-HMPAO SPECT study with automated Brodmann areas analysis.
    Valotassiou V; Sifakis N; Tzavara C; Lykou E; Tsinia N; Kamtsadeli V; Sali D; Angelidis G; Psimadas D; Tsougos I; Papageorgiou SG; Georgoulias P; Papatriantafyllou J
    Int J Psychiatry Clin Pract; 2022 Mar; 26(1):14-22. PubMed ID: 33207961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eating Disorders in Frontotemporal Dementia and Alzheimer's Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis.
    Valotassiou V; Sifakis N; Tzavara C; Lykou E; Tsinia N; Kamtsadeli V; Sali D; Angelidis G; Psimadas D; Tsougos I; Papageorgiou SG; Georgoulias P; Papatriantafyllou J
    J Alzheimers Dis; 2021; 80(4):1657-1667. PubMed ID: 33720894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain perfusion SPECT with Brodmann areas analysis in differentiating frontotemporal dementia subtypes.
    Valotassiou V; Papatriantafyllou J; Sifakis N; Tzavara C; Tsougos I; Psimadas D; Kapsalaki E; Fezoulidis I; Hadjigeorgiou G; Georgoulias P
    Curr Alzheimer Res; 2014; 11(10):941-54. PubMed ID: 25387340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion SPECT studies with mapping of Brodmann areas in differentiating Alzheimer's disease from frontotemporal degeneration syndromes.
    Valotassiou V; Papatriantafyllou J; Sifakis N; Tzavara C; Tsougos I; Kapsalaki E; Hadjigeorgiou G; Georgoulias P
    Nucl Med Commun; 2012 Dec; 33(12):1267-76. PubMed ID: 23018627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment.
    Tranfaglia C; Palumbo B; Siepi D; Sinzinger H; Parnetti L
    Hell J Nucl Med; 2009; 12(2):110-4. PubMed ID: 19675861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Evaluation of Brain Perfusion SPECT with Brodmann Areas Mapping in Early Diagnosis of Alzheimer's Disease.
    Valotassiou V; Papatriantafyllou J; Sifakis N; Tzavara C; Tsougos I; Psimadas D; Fezoulidis I; Kapsalaki E; Hadjigeorgiou G; Georgoulias P
    J Alzheimers Dis; 2015; 47(3):773-85. PubMed ID: 26401711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Neuropsychiatric Symptoms in Dementia with Brain Perfusion: A 99mTc-SPECT-HMPAO Study with Brodmann Areas Analysis.
    Valotassiou V; Sifakis N; Tzavara C; Lykou E; Tsinia N; Kamtsadeli V; Sali D; Angelidis G; Psimadas D; Tsougos I; Papageorgiou SG; Georgoulias P; Papatriantafyllou J
    Curr Alzheimer Res; 2021; 18(12):970-983. PubMed ID: 34931963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPECT analysis and language profile in Greek speaking patients with subtypes of frontotemporal dementia.
    Mamouli D; Stavrakaki S; Iakovou I; Parisis D; Karacostas D; Papanastasiou E; Ioannidis P
    Hell J Nucl Med; 2022; 25(1):43-56. PubMed ID: 35388804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain SPECT findings of anosognosia in Alzheimer's disease.
    Sedaghat F; Dedousi E; Baloyannis I; Tegos T; Costa V; Dimitriadis AS; Baloyannis SJ
    J Alzheimers Dis; 2010; 21(2):641-7. PubMed ID: 20555149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
    Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
    Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer's type: a semiquantitative and automated evaluation.
    Staffen W; Bergmann J; Schönauer U; Zauner H; Kronbichler M; Golaszewski S; Ladurner G
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):801-10. PubMed ID: 19137294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosognosia in mild Alzheimer's disease is correlated with not only neural dysfunction but also compensation.
    Tagai K; Shinagawa S; Kada H; Inamura K; Nagata T; Nakayama K
    Psychogeriatrics; 2018 Mar; 18(2):81-88. PubMed ID: 29409154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DSC Brain Perfusion Using Advanced Deconvolution Models in the Diagnostic Work-up of Dementia and Mild Cognitive Impairment: A Semiquantitative Comparison with HMPAO-SPECT-Brain Perfusion.
    Schmidt MA; Engelhorn T; Lang S; Luecking H; Hoelter P; Fröhlich K; Ritt P; Maler JM; Kuwert T; Kornhuber J; Doerfler A
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32527014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variations in regional SPECT hypoperfusion and clinical features in frontotemporal dementia.
    McMurtray AM; Chen AK; Shapira JS; Chow TW; Mishkin F; Miller BL; Mendez MF
    Neurology; 2006 Feb; 66(4):517-22. PubMed ID: 16505304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct patterns of medial temporal impairment in degenerative dementia: a brain SPECT perfusion study in Alzheimer's disease and frontotemporal dementia.
    Basely M; Ceccaldi M; Boyer L; Mundler O; Guedj E
    Eur J Nucl Med Mol Imaging; 2013 Jun; 40(6):932-42. PubMed ID: 23553080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.
    Archer HA; Smailagic N; John C; Holmes RB; Takwoingi Y; Coulthard EJ; Cullum S
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD010896. PubMed ID: 26102272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.